Eam Investors, LLC Axogen, Inc. Transaction History

Eam Investors, LLC

$581 Million
Q3 2024

A detailed history of Eam Investors, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Eam Investors, LLC holds 70,076 shares of AXGN stock, worth $1.01 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

70,076

Holding current value

$1.01 Million

% of portfolio

0.17%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.52 - $14.69 $526,971 - $1.03 Million	70,076 New	70,076 $982,000
Q4 2022 Feb 14, 2023	SELL	$9.44 - $13.09 $269,228 - $373,326	-28,520 Reduced 20.55%	110,252 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $1.13 Million - $1.7 Million	138,772 New	138,772 $1.65 Million
Q3 2018 Nov 08, 2018	SELL	$34.05 - $55.9 $2.59 Million - $4.24 Million	-75,926 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$36.15 - $52.5 $1.6 Million - $2.32 Million	-44,127 Reduced 36.76%	75,926 $3.82 Million
Q1 2018 May 14, 2018	SELL	$24.4 - $40.25 $1.05 Million - $1.74 Million	-43,128 Reduced 26.43%	120,053 $4.38 Million
Q4 2017 May 21, 2018	SELL	$18.5 - $28.6 $1.02 Million - $1.57 Million	-54,975 Reduced 25.2%	163,181 $4.62 Million
Q4 2017 Feb 12, 2018	SELL	$18.5 - $28.6 $1.36 Million - $2.1 Million	-73,412 Reduced 25.18%	218,156 $6.17 Million
Q3 2017 Nov 08, 2017	BUY	$14.65 - $19.35 $4.27 Million - $5.64 Million	291,568	291,568 $5.64 Million

Others Institutions Holding AXGN

# of Institutions

163

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

First Light Asset Management, LLC Edina, MN

4.09M
Shares

$59.2 Million
5.0% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$47.1 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.01M
Shares

$43.5 Million
3.58% of portfolio
Morgan Stanley New York, NY

2.9M
Shares

$42 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$35.1 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $612M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Account